Resolve Therapeutics' Debt Round

Resolve Therapeutics raised a round of funding on April 25, 2012.

Resolve Therapeutics is a private biotechnology company focusing on the advancement of a biologic compound, RSLV-125 from preclinical research through a phase IIa clinical trial to improve the lives o…

Articles about Resolve Therapeutics' Debt Round: